Keywords: TxCell, Fund raising, OvaSave, Development, Crohn's disease

TxCell raises 12.4 million euros to progress OvaSave

Article | 26 November 2012

Print This

French biotech firm TxCell SA has raised 12.4 million euros ($16.1 million) in a third financing round. This additional capital was provided ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in